Literature DB >> 6251790

In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.

O Sorensen, D Perry, S Dales.   

Abstract

Suckling rats of three inbred and three outbred strains were inoculated intraperitoneally (P) or intracerebrally (IC) with the JHM strain of mouse hepatitis virus (JHMV) and were monitored for evidence of neurologic diseases. Consequences of varying age at inoculation, route of injection, and virus dose were ascertained. No disease was evident after IP injection but IC inoculation with at least 10(4) plaque-forming units at 2 days of age resulted in either a rapidly fatal encephalitis or a chronic, progressive, fatal neurologic disease in most rats, regardless of strain. Inoculation at 5 or 10 days of age predominantly caused the chronic neurologic disease, characterized by demyelinating lesions in the brain, spinal cord, or optic nerve, which sometimes were evident as late as several months postinoculation. Demyelination in the optic nerve proved to be concurrent with demyelinating lesions elsewhere in the CNS. Occasionally, clinical remissions were observed in rats in which posterior paralysis developed, suggesting that remyelination in the rat can occur. Demonstration of virus replication, by infectivity, in rats exhibiting neurologic disease and in rats without clinical symptoms was substantiated by electron microscopic observations of virus development and assembly in oligodendroglia of the optic nerve and spinal cord. In view of the protracted course of the disease in some rats, presence of demyelinating lesions confirmed by light and electron microscopy, and remissions of clinical symptoms, the JHMV-infected rat seems to be an appropriate animal model to study virus-mediated progressive demyelinating disease.

Entities:  

Mesh:

Year:  1980        PMID: 6251790     DOI: 10.1001/archneur.1980.00500570026003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  62 in total

1.  In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.

Authors:  S Beushausen; S Narindrasorasak; B D Sanwal; S Dales
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system.

Authors:  J D Sedgwick; S Schwender; H Imrich; R Dörries; G W Butcher; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

3.  T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system.

Authors:  M A Sussman; R A Shubin; S Kyuwa; S A Stohlman
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

Authors:  J O Fleming; M D Trousdale; F A el-Zaatari; S A Stohlman; L P Weiner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

Review 5.  MicroRNA 155 and viral-induced neuroinflammation.

Authors:  Laura L Dickey; Timothy M Hanley; Thomas B Huffaker; Andrew G Ramstead; Ryan M O'Connell; Thomas E Lane
Journal:  J Neuroimmunol       Date:  2017-01-24       Impact factor: 3.478

6.  Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice.

Authors:  R L Knobler; L A Tunison; P W Lampert; M B Oldstone
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

7.  Coronavirus JHM-induced demyelinating encephalomyelitis in rats: influence of immunity on the course of disease.

Authors:  H Wege; R Watanabe; M Koga; V Ter Meulen
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

8.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

9.  Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.

Authors:  J M Pasick; S Dales
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

Authors:  O Sorensen; M B Coulter-Mackie; S Puchalski; S Dales
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.